We need a breakthrough
in kidney health.
We need YOU.

We need a breakthrough
in kidney health.
We need YOU.

We need a breakthrough
in kidney health.
We need YOU.

We need a breakthrough
in kidney health.
We need YOU.

We need a breakthrough
in kidney health.
We need YOU.

Almost
1 in 7
people suffer from a
kidney condition

Each year, kidney disease
kills more people
than breast or prostate cancer

The importance of kidney health

Your kidneys are important to your health. They remove waste from your body and help to keep your blood pressure normal. But your kidneys are at risk for chronic disease and acute injury.

Chronic kidney disease is often called the “silent disease” because it has no symptoms in its early stages. It can go undetected until it is very advanced.

 

We need breakthroughs to prevent and treat kidney injury and disease.

The promise of Precision Medicine

The National Institutes of Health defines precision medicine as a new way of treating and preventing disease, which takes into account our genes, our environment, and our lifestyles.
Precision medicine will help doctors and researchers better predict which treatment and prevention steps will work on which groups of people.

It is different from a one-size-fits-all approach, which does not consider the differences between patients.

Who can join?

We need people from all walks of life, races, and age groups to give us the most accurate and complete kidney information.

By joining, you will help transform the future of kidney health.

 

You may be eligible to join if:

You have chronic kidney disease

You have an acute kidney injury

You cannot join the study if you have had a kidney transplant or are on dialysis

What will be expected of me?

KPMP is a study that can last up to 10 years. In order to participate, we will ask you to do the following:

Undergo a kidney biopsy

Provide samples like blood and urine

Talk to the study team two to three times a year

How do I join?

If you would like to learn more about participating in the study, please contact your nearest recruitment site below.

Chronic Kidney Disease (CKD)

Massachusetts

Brigham & Women’s Hospital
(Boston)

Zoe Kibbelaar
zkibbelaar@bwh.harvard.edu
(617) 638-7332

Site investigator:
Sushrut Waikar, MD, MPH

 

Joslin Diabetes Center/Beth Israel Deaconess Medical Center
(Boston)

Alison Slack
KPMP@joslin.harvard.edu
(617) 309-4130

Site investigator:
Sylvia Rosas, MD

Ohio

Cleveland Clinic
(Cleveland)

Leslie Cooperman, RN
COOPERL2@ccf.org
(216) 444-7954

Site investigator:
John Sedor, MD

Texas

UT Southwestern
(Dallas)

Nancy Weng
Zhengnan.Wang@UTSouthwestern.edu
(214) 615-8291

Site investigator:
Miguel Vasquez, MD

Acute Kidney Injury (AKI)

Connecticut

Yale University
(New Haven)

Tanima Arora
tanima.arora@yale.edu
(203) 737-1787

Site investigator:
F. Perry Wilson, MD

Maryland

Johns Hopkins University
(Baltimore)

Pam Corona Villalobos, MD
pamelacorona@jhmi.educoordinator@email.edu
(410) 955-3852

Site investigator:
Chirag Parikh, MD, PhD

New York

Columbia University
(New York)

Karla Mehl, MD
km3246@cumc.columbia.edu
(212) 851-5216

Site investigator:
Andrew Bomback, MD, MPH

Pennsylvania

University of Pittsburgh
(Pittsburgh)

KPMP team
MacroICUScreen@upmc.edu
(412) 958-0957

Site investigator:
John Kellum, MD

Translate »